MF40 Automated Punch and Die Polishing Machine - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

MF40 Automated Punch and Die Polishing Machine

Pharmaceutical Technology
Volume 37, Issue 9, pp. 14
I Holland MF40 Punch and Die Polishing

I Holland has introduced the next generation to its range of MF polishers, the MF40 automated punch, and die polishing machine. The stainless-steel construction is highly durable and easy to clean, according to the company.  A 40 L media drum and increased capacity holders allow for up to17 B or 12 D punches per holder giving a maximum of 51 B or 36 D punches per polishing cycle.  The MF40 uses single-phase power and fits in the same compact 940 x 750 mm footprint as the MF35. The MF40 polishing machine was developed to be used as part of I Holland’s PharmaCare 7-Step Process, a professional maintenance and storage program.

I Holland


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: Pharmaceutical Technology,
Click here